Greenland Mines Ltd. Common Stock (NASDAQ:GRML) Issues Quarterly Earnings Results

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) issued its earnings results on Wednesday. The company reported ($0.15) earnings per share (EPS) for the quarter, FiscalAI reports.

Greenland Mines Ltd. Common Stock Trading Up 14.8%

GRML traded up $0.05 during trading on Wednesday, hitting $0.39. 3,126,768 shares of the company traded hands, compared to its average volume of 3,362,771. The company has a market cap of $47.10 million, a PE ratio of -1.21 and a beta of 7.61. The stock’s 50-day simple moving average is $0.50 and its two-hundred day simple moving average is $0.42. Greenland Mines Ltd. Common Stock has a 1 year low of $0.16 and a 1 year high of $3.91.

Hedge Funds Weigh In On Greenland Mines Ltd. Common Stock

Several institutional investors have recently bought and sold shares of the stock. Jane Street Group LLC purchased a new position in Greenland Mines Ltd. Common Stock during the second quarter valued at $26,000. XTX Topco Ltd increased its stake in Greenland Mines Ltd. Common Stock by 101.2% in the 4th quarter. XTX Topco Ltd now owns 160,569 shares of the company’s stock worth $46,000 after acquiring an additional 80,768 shares during the last quarter. Geode Capital Management LLC increased its stake in Greenland Mines Ltd. Common Stock by 51.8% in the 4th quarter. Geode Capital Management LLC now owns 491,832 shares of the company’s stock worth $142,000 after acquiring an additional 167,905 shares during the last quarter. Renaissance Technologies LLC bought a new stake in Greenland Mines Ltd. Common Stock in the 4th quarter worth approximately $126,000. Finally, Brummer Multi Strategy AB bought a new stake in Greenland Mines Ltd. Common Stock in the 4th quarter worth approximately $175,000. 20.07% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on GRML shares. Weiss Ratings reissued a “sell (e+)” rating on shares of Greenland Mines Ltd. Common Stock in a research report on Wednesday, April 22nd. Wall Street Zen raised Greenland Mines Ltd. Common Stock to a “sell” rating in a research note on Saturday, May 2nd. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

About Greenland Mines Ltd. Common Stock

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases – cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.